Search
for
Sort by
Research 121–150 of 1000+
- A conditional multi-trait sequence GWAS discovers pleiotropic candidate genes and variants for sheep wool, skin wrinkle and breech cover traits
- The epidermal growth factor receptor decreases Stathmin 1 and triggers catagen entry in the mouse
- Emerging role of ILK and ELMO2 in the integration of adhesion and migration pathways
- Epidermal Growth Factor Receptor Inhibitors: Cutaneous Side Effects and Their Management.
- The Epithelial Stem Cell Niche in Skin
- Histopathologic features of erythematous papulopustular eruption to epidermal growth factor receptor inhibitors in cancer patients
- TCDD-induced activation of aryl hydrocarbon receptor regulates the skin stem cell population
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- MiR‐200c‐3p as a novel genetic marker and therapeutic tool for alopecia areata
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- The trichoscopic features of hair shaft anomalies induced by epidermal growth factor receptor inhibitors: A case series
- An overview of management of drug-induced hair and nail disorders
- Gefitinib-induced hair alterations: Figure 1
- Novel Application of Layered Expression Scanning for Proteomic Profiling of Plucked Hair Follicles
- Histochemistry of the porcine pilosebaceous unit
- RNA sequence analysis of dermal papilla cells’ regeneration in 3D culture
- Regulation and Role of GLI1 in Cutaneous Squamous Cell Carcinoma Pathogenesis
- Successful treatment of epidermal growth factor receptor inhibitor–induced alopecia with doxycycline
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Epidermal growth factor receptor/mitogen-activated kinase inhibitor treatment induces a distinct inflammatory hair follicle response that includes collapse of immune privilege
- Eyelash Trichomegaly: A Rare Presenting Feature of Systemic Lupus Erythematosus.
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- An unusual terminal hair growth on the nose tip associated with gefitinib therapy
- Radiofrequency Currents Modulate Inflammatory Processes in Keratinocytes
- Mathematical Modeling and Inference of Epidermal Growth Factor-Induced Mitogen-Activated Protein Kinase Cell Signaling Pathways
- Accelerative action of topical piperonylic acid on mice full thickness wound by modulating inflammation and collagen deposition
- Prevention of erlotinib-induced folliculitis with doxycycline
- “Arrow” sign: A rapid microscopic diagnosis of hair change associated with epidermal growth factor receptor inhibitors